Radiopharm Theranostics RADX
NASDAQ RADX
$1.42 -0.06 (-4.05%)
At close: Oct 2, 2026 · 4:00 PM EDT

Radiopharm Theranostics (RADX) Other Non Operating Income (2024 - 2026)

Updated

Radiopharm Theranostics (RADX) reported Other Non Operating Income of $72,904 for FY2026 (year ended Jun 30, 2026), up 11.0% from $65,688 in FY2025.

Analysis

Radiopharm Theranostics (RADX) Other Non Operating Income (2024 - 2026) Analysis & Trends

  • According to Business Quant data, Other Non Operating Income came in at $65,688 in FY2025 (+642.1%) and $8,851 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Radiopharm Theranostics 5.25 Bn 5.21 Bn 186,835.86
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -615,833.59
Jun 30, 2025 -225,205.77
Jun 30, 2024 -808,035.19
API Access

Radiopharm Theranostics Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=RADX&period=max&api_key=YOUR_API_KEY